Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urticaria and Angioedema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT04898309
What this trial is testing

Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
AO GENERIUM
Not applicableLooking for participantsNCT07293364
What this trial is testing

Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 514
Testing effectiveness (Phase 2)Study completedNCT03712228
What this trial is testing

Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
CSL Behring 44
Not applicableStudy completedNCT04861090
What this trial is testing

A Study in Teenagers and Adults With Hereditary Angioedema (HAE) Type I or Type II Who Use Lanadelumab as Long-Term Prophylaxis

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 207
Not applicableStudy completedNCT01059526
What this trial is testing

Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 81
Testing effectiveness (Phase 2)Study completedNCT04618211
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 74
Large-scale testing (Phase 3)Study completedNCT04687137
What this trial is testing

Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Takeda 12
Large-scale testing (Phase 3)Study completedNCT01723072
What this trial is testing

Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy

Who this might be right for
Chronic Spontaneous UrticariaAngioedema
Novartis Pharmaceuticals 91
Large-scale testing (Phase 3)Enrolling By InvitationNCT05396105
What this trial is testing

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+14 more
Pharvaris Netherlands B.V. 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT05691361
What this trial is testing

Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients

Who this might be right for
Hereditary Angioedema
ADARx Pharmaceuticals, Inc. 53
Not applicableNot Yet RecruitingNCT07218393
What this trial is testing

A Study About the Diagnosis and Management of Hereditary Angioedema (HAE) in Egypt

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 100
Not applicableStudy completedNCT00004694
What this trial is testing

Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations

Who this might be right for
Angioedema
University of Iowa 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05121376
What this trial is testing

A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHAE
BioMarin Pharmaceutical 44
Post-approval studies (Phase 4)Looking for participantsNCT06818474
What this trial is testing

Lanadelumab in Long-term Prophylaxis of Acquired Angioedema

Who this might be right for
Angioedema
Bernstein Clinical Research Center 5
Not applicableEnded earlyNCT02854397
What this trial is testing

Determination of Specific Biomarkers of Acute Attack of Angioedema Within Pediatric Population

Who this might be right for
Hereditary AngioedemaHealthy Volunteers
University Hospital, Grenoble 31
Large-scale testing (Phase 3)Study completedNCT02303626
What this trial is testing

12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks

Who this might be right for
Hereditary AngioedemaHAE
BioCryst Pharmaceuticals 110
Post-approval studies (Phase 4)Ended earlyNCT01574248
What this trial is testing

Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema

Who this might be right for
ACE Inhibitor-associated Angioedema
Vanderbilt University Medical Center 33
Not applicableActive Not RecruitingNCT05469789
What this trial is testing

Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 50
Large-scale testing (Phase 3)Study completedNCT02741596
What this trial is testing

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 212
Early research (Phase 1)Study completedNCT05477160
What this trial is testing

STAR-0215 in Healthy Adult Participants

Who this might be right for
Hereditary Angioedema
Astria Therapeutics, Inc. 41
Next Page